logo-loader

Zelda Therapeutics to increase cash position

Published: 10:30 28 Mar 2017 AEDT

money_on_financial_documents,_sized_58d99b7538465
Zelda is focused on medicinal cannabis research

Zelda Therapeutics (ASX:ZLD) has been granted a trading halt by the ASX, pending details of a capital raising.

The halt will remain in place until the opening of trade on Thursday 30th March 2017, or earlier if an announcement is made to the market.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

7 hours, 21 minutes ago